Clinical Trial Update: Oral Microbiota Dysbiosis in IBD

View source ↗

Summary

This clinical trial update describes a study on oral microbiota dysbiosis in inflammatory bowel disease, sponsored by ULS Viseu Dão Lafões, which is currently n…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Inflammatory Bowel Disease

Snippet

Sponsor: ULS Viseu Dão Lafões | Conditions: Inflammatory Bowel Disease (IBD), Dysbiosis | Status: ACTIVE_NOT_RECRUITING